procaine has been researched along with Adrenal Cancer in 1 studies
Procaine: A local anesthetic of the ester type that has a slow onset and a short duration of action. It is mainly used for infiltration anesthesia, peripheral nerve block, and spinal block. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1016).
procaine : A benzoate ester, formally the result of esterification of 4-aminobenzoic acid with 2-diethylaminoethanol but formed experimentally by reaction of ethyl 4-aminobenzoate with 2-diethylaminoethanol.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, J | 1 |
| Lecanu, L | 1 |
| Han, Z | 1 |
| Yao, Z | 1 |
| Greeson, J | 1 |
| Papadopoulos, V | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study Of Orally Administered SP01A As Monotherapy Treatment Of HIV-Infected Patients[NCT00113412] | Phase 2 | 32 participants | Interventional | 2005-05-31 | Active, not recruiting | ||
| A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study of Orally Administered SP01A for 28 Days as Monotherapy Treatment in HIV-Infected Patients With Evidence of Resistance to Currently Available Antiretroviral Therapy[NCT00299897] | Phase 2 | 60 participants | Interventional | 2006-03-31 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for procaine and Adrenal Cancer
| Article | Year |
|---|---|
Inhibition of adrenal cortical steroid formation by procaine is mediated by reduction of the cAMP-induced 3-hydroxy-3-methylglutaryl-coenzyme A reductase messenger ribonucleic acid levels.
Topics: Adrenal Cortex; Adrenal Gland Neoplasms; Anesthetics, Local; Animals; Bucladesine; Cell Line, Tumor; | 2003 |
Inhibition of adrenal cortical steroid formation by procaine is mediated by reduction of the cAMP-induced 3-hydroxy-3-methylglutaryl-coenzyme A reductase messenger ribonucleic acid levels.
Topics: Adrenal Cortex; Adrenal Gland Neoplasms; Anesthetics, Local; Animals; Bucladesine; Cell Line, Tumor; | 2003 |
Inhibition of adrenal cortical steroid formation by procaine is mediated by reduction of the cAMP-induced 3-hydroxy-3-methylglutaryl-coenzyme A reductase messenger ribonucleic acid levels.
Topics: Adrenal Cortex; Adrenal Gland Neoplasms; Anesthetics, Local; Animals; Bucladesine; Cell Line, Tumor; | 2003 |
Inhibition of adrenal cortical steroid formation by procaine is mediated by reduction of the cAMP-induced 3-hydroxy-3-methylglutaryl-coenzyme A reductase messenger ribonucleic acid levels.
Topics: Adrenal Cortex; Adrenal Gland Neoplasms; Anesthetics, Local; Animals; Bucladesine; Cell Line, Tumor; | 2003 |